Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby

LOBBYING REGISTRATION

Lobbying Disclosure Act of 1995 (Section 4)

Check One: New Registrant New Client for Existing Registrant Amendment

1. Effective Date of Registration
05/19/2008
2. House Identification
 34506
 Senate Identification
 48793

REGISTRANT Organization/Lobbying Firm Self Employed Individual

3. Registrant Organization
ACADEMY OF MANAGED CARE PHARMACY
Address
100 NORTH PITT STREET, #400
 Address2
​
City
ALEXANDRIA
 State
VA
 Zip
22314
 Country
USA

4. Principal place of business (if different than line 3)

City
​
 State
​
 Zip
​
 Country
​
5. Contact name and telephone number International Number
Contact
​Mr. William Hermelin
 Telephone
​7036838416
 E-mail
​bhermelin@amcp.org
6. General description of registrant’s business or activities
​Promotion of sound medication management principles and strategies.

CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self

7. Client name
​ACADEMY OF MANAGED CARE PHARMACY
Address
​
City
​
 State
​
 Zip
​
 Country
​USA
8. Principal place of business (if different than line 7)
City
​
 State
​
 Zip
​
 Country
​
9. General description of client’s business or activities
​

LOBBYISTS

10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.

Name Covered Official Position (if applicable)
First
Last
Suffix
​William (Bill) ​Hermelin ​ ​
​Melissa ​Andel ​ ​
​Ryan ​Day ​ ​
​Lauren ​Fuller ​ ​Chief Investigative Counsel, U.S. Senate Cmte. on Finance
​ ​ ​ ​

LOBBYING ISSUES

11. General lobbying issue areas (Select all applicable codes).

​HCR
​MMM
​PHA
​
​
​
​
​
​

12. Specific lobbying issues (current and anticipated)

Proposed changes to the Medicare prescription drug benefit; adjustments to Medicaid prescription drug reimbursement rates; FDA issues, including establishment of a regulatory pathway for approval of "follow-on" biologic drug products, additional monitoring of direct-to-consumer advertisements of prescription drugs and additional agency funding; funding for comparative effectiveness research; health information technology/e-prescribing; importation of prescription drugs/counterfeit drugs

AFFILIATED ORGANIZATIONS

13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?

No --> Go to line 14. Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14.
Internet Address:
​
Name Address Principal Place of Business
Street
City State/Province Zip Code Country
​
​
City
​
​
​
​
​
State
​
 Country
​
​
​
City
​
​
​
​
​
State
​
 Country
​
​
​
City
​
​
​
​
​
State
​
 Country
​

FOREIGN ENTITIES

14. Is there any foreign entity

a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or

b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or

c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?

No --> Sign and date the registration. Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration.
Address Ownership
Name Street Principal place of business Amount of contribution
City State/Province Country
(city and state or country) for lobbying activities
​
City
​
​
​
​
​
State
​
 Country
​
​
​
 %
​
City
​
​
​
​
​
State
​
 Country
​
​
​
 %
Signature
Digitally Signed By: William Hermelin, Director of Government Relations and General Counsel
 Date
07/01/2008